IVAZIDE Trademark

Trademark Overview

On Thursday, March 17, 2016, a trademark application was filed for IVAZIDE with the United States Patent and Trademark Office. The USPTO has given the IVAZIDE trademark a serial number of 86943635. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 10, 2019. This trademark is owned by Exela Innovations. The IVAZIDE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of diuresis and hypertension by parenteral administration
ivazide

General Information

Serial Number86943635
Word MarkIVAZIDE
Filing DateThursday, March 17, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 10, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2016

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of diuresis and hypertension by parenteral administration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameExela Innovations
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645
Party NameExela Innovations
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645

Trademark Events

Event DateEvent Description
Monday, June 10, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 10, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 8, 2018EXTENSION 4 GRANTED
Thursday, November 8, 2018EXTENSION 4 FILED
Thursday, November 8, 2018TEAS EXTENSION RECEIVED
Thursday, April 26, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 25, 2018EXTENSION 3 GRANTED
Wednesday, April 25, 2018EXTENSION 3 FILED
Wednesday, April 25, 2018TEAS EXTENSION RECEIVED
Thursday, November 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2017EXTENSION 2 GRANTED
Tuesday, November 7, 2017EXTENSION 2 FILED
Tuesday, November 7, 2017TEAS EXTENSION RECEIVED
Tuesday, May 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 5, 2017EXTENSION 1 GRANTED
Friday, May 5, 2017EXTENSION 1 FILED
Friday, May 5, 2017TEAS EXTENSION RECEIVED
Wednesday, March 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 29, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 29, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 21, 2016ASSIGNED TO LIE
Thursday, July 14, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 29, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 29, 2016NON-FINAL ACTION E-MAILED
Wednesday, June 29, 2016NON-FINAL ACTION WRITTEN
Tuesday, June 28, 2016ASSIGNED TO EXAMINER
Tuesday, March 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 21, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

ivazide parenteral administration hypertension diuresis preparations treatment pharmaceutical